RecruitingPHASE1, PHASE2NCT05508009
Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor
Studying Cystinosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Alice Bertaina
- Principal Investigator
- Alice Bertaina, MDStanford University
- Intervention
- Cyclophosphamide 1200 mg/Kg(drug)
- Enrollment
- 12 enrolled
- Eligibility
- 1-30 years · All sexes
- Timeline
- 2023 – 2034
Study locations (1)
- Lucile Packard Children's Hospital, Palo Alto, California, United States
Collaborators
California Institute for Regenerative Medicine (CIRM)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05508009 on ClinicalTrials.govOther trials for Cystinosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT05994534PK and PD Study of NPI-001 and Cysteamine BitartrateNacuity Pharmaceuticals, Inc.
- ENROLLING BY INVITATIONNANCT05146830A Long-Term Follow-Up Study of Participants With Cystinosis Who Previously Received CTNS-RD-04Stephanie Cherqui
- RECRUITINGNANCT05959668Development of Health-related Quality of Life Instrument for Patients With CystinosisCystinose Stiftung
- RECRUITINGNANCT05843851Genetic Newborn Screening for Cystinosis and Primary HyperoxaluriaCystinose Stiftung
- ENROLLING BY INVITATIONNCT04246060Observational Study to Assess the Quality of Life in Nephropathic Cystinosis PatientsChiesi SA/NV
- RECRUITINGNCT05901077European Cystinosis CohortInstitut National de la Santé Et de la Recherche Médicale, France
- RECRUITINGNANCT00359684Use of Cysteamine in the Treatment of CystinosisNational Human Genome Research Institute (NHGRI)